Vendor, Pawtucket, RI
Eascra Biotech, Inc.
UEI NDU4YKLLPTQ1, CAGE 99B88
2 awards and $5,324,974 obligated between August 2, 2024 and June 2, 2026, 50% under full and open competition, against 500.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Aeronautics and Space Administration | $5,250,000 |
| Department of the Air Force | $74,974 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $5,324,974 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 80JSC026C0005Definitive Contract, May 13, 2026, Full and Open Competition, 1 offers | NASA Johnson Space CenterNational Aeronautics and Space Administration | Eascra BiotechNAICS 541715, PSC AR13 | $5,250,000 |
| FA864924P0958Purchase Order, August 2, 2024, Full and Open Competition After Exclusion of Sources, 999 offers | FA8649 USAF SBIR STTR Cntrctng AFRLDepartment of the Air Force | Enhancing Military Medical Response: the Potential of Janus Base Nanoparticle (Jbns) in Combat Injury Rehabilitation and Pain ManagementNAICS 541715, PSC AC32 | $74,974 |
- Places of performance
- Rhode Island
- Product and service codes
- AR13 Space R&D Services; Space Flight, Research And Supporting Activities; Experimental DevelopmentAC32 National Defense R&D Services; Defense-Related Activities; Applied Research
- Transactions
- 4 across 2 awards